Displaying drugs 7626 - 7650 of 7886 in total
BMS-599626
BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
Investigational
2,5-Diaminopyrimidin-4,6-diol
Experimental
Irosustat
Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.
Investigational
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
Experimental
Flaviolin
Experimental
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
3,4-Dihydroxy-1-Methylquinolin-2(1h)-One
Experimental
L-Leucyl-Hydroxylamine
Experimental
2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE
Experimental
Gossypol
Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
Investigational
Pheneturide
Experimental
Bis(5-Amidino-2-Benzimidazolyl)Methanone
Experimental
1,3-diphenylurea
Experimental
(R)-warfarin
Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
Experimental
Propamidine
Experimental
Investigational
DOTMP HO-166
DOTMP HO-166 is used in skeletal targeted radiotherapy (STR). SRT is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow. It is an experimental therapy...
Investigational
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
Cibenzoline
Experimental
(S)-Warfarin
Warfarin consists of a racemic mixture of two active enantiomers—R- and S- forms—each of which is cleared by different pathways. S-warfarin is 2-5 times more potent than the R-isomer in producing an anticoagulant response.
Experimental
Investigational
Displaying drugs 7626 - 7650 of 7886 in total